Coriobacteriia may affect the occurrence of hepatocellular carcinoma through the pyrimidine, caffeine, urea cycle and glutamate metabolic pathways

科里奥杆菌可能通过嘧啶、咖啡因、尿素循环和谷氨酸代谢途径影响肝细胞癌的发生。

阅读:1

Abstract

Most patients with hepatocellular carcinoma (HCC) lose the chance of survival due to lack of timely diagnosis and effective treatment. The specific gut microbiota (GM) spectrum may become the target of early diagnosis and treatment of HCC. However, the metabolic mechanisms that affect the occurrence of liver cancer are still unclear. In this study, we called the dataset of HCC, and 1091 serum metabolites 309 metabolite ratios as well as 211 GM taxa through genome-wide association studies instrumental variables for Mendelian randomization causal association analysis and metabolome intermediary effects exploration. Through functional enrichment of intermediate metabolites, the effects of metabolic pathways involved in GM on HCC were analyzed. Inverse variance weighting was the main model for establishing causal associations. Additionally horizontal pleiotropy test, linkage-disequilibrium test and the sensitivity analysis were employed to test the explanatory power of instrumental variables (single nucleotide polymorphisms). Our study found Coriobacteriia class, Coriobacteriales order, Coriobacteriaceae family, and 4 specific genera were strongly related to HCC (P <.05). Meanwhile, through 2 samples-MR Analysis, 49 metabolites levels/ratios were shown to be closely related to the development of HCC. A total of 10 related metabolic intermediary factors have been selected, and 4 metabolic pathways of pyrimidine (P = .0031), caffeine (P = .0072), urea cycle (P = .0105) and glutamate (P = .0298) were significantly enriched in this GM related HCC process. Coriobacteriia class and its lower taxa were associated with the risk factors of developing HCC through the regulation of pyrimidine, caffeine, urea cycle and glutamate metabolic pathways. These GM taxa and metabolitesmay serve as potential targets for the diagnosis of HCC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。